1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Medical Second Opinion Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Medical Second Opinion Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Growing emphasis on better treatment outcomes Favors Market Growth
5.2 Market Opportunities
- 5.2.1 Increasing collaborations in telemedicine technologies are likely to create ample opportunities in the coming years
5.3 Future Trends
- 5.3.1 Increasing digitalization of medical consulting services expected to be the future trends in coming years
5.4 Impact of Drivers and Restraints
6. North America Medical Second Opinion Market Regional Analysis
6.1 North America Medical Second Opinion Market Overview
6.2 North America Medical Second Opinion Market Revenue 2018-2027 (US$ Million)
6.3 North America Medical Second Opinion Market Forecast Analysis
7. North America Medical Second Opinion Market Analysis – by Disorders
7.1 Cancer
- 7.1.1 Overview
- 7.1.2 Cancer: North America Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Orthopedic Disorders
- 7.2.1 Overview
- 7.2.2 Orthopedic Disorders: North America Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Cardiac Disorders
- 7.3.1 Overview
- 7.3.2 Cardiac Disorders: North America Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Neurological Disorders
- 7.4.1 Overview
- 7.4.2 Neurological Disorders: North America Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Nephrological Disorders
- 7.5.1 Overview
- 7.5.2 Nephrological Disorders: North America Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Hematologic Blood Disorders
- 7.6.1 Overview
- 7.6.2 Hematologic Blood Disorders: North America Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.7 COPD
- 7.7.1 Overview
- 7.7.2 COPD: North America Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Organ Transplant
- 7.8.1 Overview
- 7.8.2 Organ Transplant: North America Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
7.9 Other Disorders
- 7.9.1 Overview
- 7.9.2 Other Disorders: North America Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Medical Second Opinion Market Analysis – by Service Providers
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: North America Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Health Insurance Companies
- 8.2.1 Overview
- 8.2.2 Health Insurance Companies: North America Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Online Services
- 8.3.1 Overview
- 8.3.2 Online Services : North America Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Medical Second Opinion Market – North America Analysis
9.1 North America
- 9.1.1 North America Medical Second Opinion Market Breakdown, by Key
Country, 2021 and 2027 (%)
- 9.1.1.1 North America Medical Second Opinion Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 US:
North America Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.1.1 US: North America Medical Second Opinion Market Breakdown, by Disorders
- 9.1.1.1.2 US: North America Medical Second Opinion Market Breakdown, by Service Providers
- 9.1.1.2 Canada:
North America Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.2.1 Canada: North America Medical Second Opinion Market Breakdown, by Disorders
- 9.1.1.2.2 Canada: North America Medical Second Opinion Market Breakdown, by Service Providers
- 9.1.1.3 Mexico :
North America Medical Second Opinion Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.3.1 Mexico : North America Medical Second Opinion Market Breakdown, by Disorders
- 9.1.1.3.2 Mexico : North America Medical Second Opinion Market Breakdown, by Service Providers
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. North America Medical Second Opinion Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Second Opinion International
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Cigna
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 WorldCare
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Medix
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 2nd.MD (Innovation Specialists LLC)
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 AXA
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
13. Appendix
13.1 About Business Market Insights